Damora Therapeutics (DMRA) Non-Current Assets (2019 - 2026)

Damora Therapeutics (DMRA) has 8 years of Non-Current Assets data on file, last reported at $34000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 92.69% year-over-year to $34000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 64.34% YoY), and the FY2025 full-year result was $127000.0, down 56.66% from the prior year.
• Non-Current Assets for Q1 2026 stood at $34000.0, down from $127000.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $11.9 million in Q1 2022 and bottomed at $34000.0 in Q1 2026.
• The 5-year median for Non-Current Assets is $2.1 million (2024), against an average of $3.9 million.
• The widest annual swing landed in 2022, when Non-Current Assets decreased 23.33%; it then sank 92.69% in 2026.
• A 5-year view of Non-Current Assets shows it stood at $9.3 million in 2022, then sank by 84.36% to $1.5 million in 2023, then tumbled by 79.83% to $293000.0 in 2024, then plunged by 56.66% to $127000.0 in 2025, then slumped by 73.23% to $34000.0 in 2026.
• The last three Non-Current Assets figures came in at $34000.0 (Q1 2026), $127000.0 (Q4 2025), and $950000.0 (Q3 2025), per Business Quant data.

Peer Comparison